Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Packer

Showing results (31-40 of 326) with videos related to

Pageof 33
Sort By:
The American Journal of Medicine|June 22, 1984
Conceptual dilemmas in the classification of vasodilator drugs for severe chronic heart failure. Advocacy of a pragmatic approach to the selection of a therapeutic agentM Packer
Progress in Cardiovascular Diseases|August 26, 1998
Beta-adrenergic blockade in chronic heart failure: principles, progress, and practiceM Packer
The American Journal of Cardiology|June 4, 1992
Long-term strategies in the management of heart failure: looking beyond ventricular function and symptomsM Packer
Drugs|January 1, 1986
The role of vasodilator therapy in the treatment of severe chronic heart failureM Packer
Cardiovascular Drugs and Therapy|January 1, 1989
Does digitalis work in chronic heart failure? The end of a 200-year-old controversyM Packer
Journal of Cardiovascular Pharmacology|January 1, 1987
Converting-enzyme inhibition in the management of severe chronic congestive heart failure: physiologic conceptsM Packer
American Heart Journal|July 1, 1985
Mechanisms of nitrate action in patients with severe left ventricular failure: conceptual problems with the theory of venosequestrationM Packer
Circulation|October 1, 1985
Sudden unexpected death in patients with congestive heart failure: a second frontierM Packer
Circulation|June 1, 1988
Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failureM Packer
Diabetic Medicine : a Journal of the British Diabetic Association|March 14, 2018
Contrasting effects on the risk of macrovascular and microvascular events of antihyperglycemic drugs that enhance sodium excretion and lower blood pressureM Packer
Pageof 33

Showing results (31-40 of 326) with videos related to

Sort By:
Pageof 33
The American Journal of Medicine|June 22, 1984
Conceptual dilemmas in the classification of vasodilator drugs for severe chronic heart failure. Advocacy of a pragmatic approach to the selection of a therapeutic agentM Packer
Progress in Cardiovascular Diseases|August 26, 1998
Beta-adrenergic blockade in chronic heart failure: principles, progress, and practiceM Packer
The American Journal of Cardiology|June 4, 1992
Long-term strategies in the management of heart failure: looking beyond ventricular function and symptomsM Packer
Drugs|January 1, 1986
The role of vasodilator therapy in the treatment of severe chronic heart failureM Packer
Cardiovascular Drugs and Therapy|January 1, 1989
Does digitalis work in chronic heart failure? The end of a 200-year-old controversyM Packer
Journal of Cardiovascular Pharmacology|January 1, 1987
Converting-enzyme inhibition in the management of severe chronic congestive heart failure: physiologic conceptsM Packer
American Heart Journal|July 1, 1985
Mechanisms of nitrate action in patients with severe left ventricular failure: conceptual problems with the theory of venosequestrationM Packer
Circulation|October 1, 1985
Sudden unexpected death in patients with congestive heart failure: a second frontierM Packer
Circulation|June 1, 1988
Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failureM Packer
Diabetic Medicine : a Journal of the British Diabetic Association|March 14, 2018
Contrasting effects on the risk of macrovascular and microvascular events of antihyperglycemic drugs that enhance sodium excretion and lower blood pressureM Packer
Pageof 33